Torrent Pharmaceuticals (TORNTPHARM.NS) Stock Chart - Revenue & Earnings | Quarter Chart
Revenue by Product
Revenue by Geography
Revenue, Gross Profit, Operating and Net Income
Margin (%)
Operating Expenses
EBITDA
EPS
Revenue Variation (%)
Income Variation (%)
Revenue YoY Variation (%)
Income YoY Variation (%)
Price-to-Earning Ratio
Income Breakdown
Per Share Metrics
Expense Ratios
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt Ratio
Current Ratio
Quick Ratio
Cash & Equivalents
Total Assets
Total Liabilities
Shareholders Equity
Asset Composition
Debt Structure
Torrent Pharmaceuticals (TORNTPHARM.NS) quarterly earnings & revenue
Torrent Pharmaceuticals (TORNTPHARM.NS) reported revenue of 435.92M INR for Q4 2026, up 44.3% year-over-year, with net income of 40.40M INR and diluted EPS of 0.12 INR.
Over the last four reported quarters, Torrent Pharmaceuticals generated 1.44B INR in revenue and 224.66M INR in net income.
Torrent Pharmaceuticals's next earnings report is scheduled for July 28, 2026; analysts estimate EPS of 0.15 INR.
Torrent Pharmaceuticals quarterly results
| Fiscal quarter | Revenue | Revenue YoY | Net income | EPS (diluted) |
|---|---|---|---|---|
| Q4 2026 | 435.92M INR | +44.3% | 40.40M INR | 0.12 INR |
| Q3 2026 | 337.66M INR | +17.7% | 65.95M INR | 0.19 INR |
| Q2 2026 | 337.14M INR | +14.7% | 61.38M INR | 0.18 INR |
| Q1 2026 | 324.89M INR | +11.1% | 56.92M INR | 0.17 INR |
| Q4 2025 | 302.17M INR | +7.9% | 51.75M INR | 0.15 INR |
| Q3 2025 | 286.87M INR | +2.6% | 52.24M INR | 0.15 INR |
| Q2 2025 | 294.04M INR | +7.7% | 47.05M INR | 0.14 INR |
| Q1 2025 | 292.38M INR | +10.5% | 47.47M INR | 0.14 INR |
Torrent Pharmaceuticals (TORNTPHARM.NS) — frequently asked questions
When does Torrent Pharmaceuticals (TORNTPHARM.NS) report earnings next?
Torrent Pharmaceuticals is expected to report earnings on July 28, 2026. Analysts estimate EPS of 0.15 INR.
What was TORNTPHARM.NS's revenue last quarter?
Torrent Pharmaceuticals reported revenue of 435.92M INR in Q4 2026, up 44.3% from the same quarter a year earlier.
What was TORNTPHARM.NS's EPS last quarter?
Torrent Pharmaceuticals reported diluted EPS of 0.12 INR in Q4 2026.
Is Torrent Pharmaceuticals profitable?
Torrent Pharmaceuticals is currently profitable, with 224.66M INR in net income over the last four reported quarters.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Roche (ROG.SW) · Merck (MRK)